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Abstract
Background: There is a need to improve design in educational programmes for the health sciences in general and
in pharmacology specifically. The objective of this study was to investigate and problematize pharmacological
communication in educational programmes for the health sciences.
Methods: An interview study was carried out where final semester students from programmes for the medical,
nursing and specialist nursing in primary health care professions were asked to discuss the pharmacological aspects
of two written case descriptions of the kind they would meet in their everyday work. The study focused on the
communication they envisaged taking place on the concerns the patients were voicing, in terms of two features:
how communication would take place and what would be the content of the communication. A phenomenographic
research approach was used.
Results: The results are presented as outcome spaces, sets of categories that describe the variation of ways in which
the students voiced their understanding of communication in the two case descriptions and showed the qualitatively
distinct ways in which the features of communication were experienced.
Conclusions: The results offer a base of understanding the students’ perspectives on communication that they will take
with them into their professional lives. We indicate that there is room for strengthening communication skills in the field
of pharmacology, integrating them into programmes of education, by more widely implementing a problem-based, a
case-oriented or role-playing pedagogy where final year students work across specialisations and there is a deliberate
effort to evoke and assess advanced conceptions and skills.
Keywords: Pharmacology, Education, Communication, Phenomenography, Case description
Background
Pharmacology as a part of the various programmes of
health care education is of increasing importance for
several reasons. The overall use of medications, multiple
medications, and medicine-related problems is increas-
ing in the general population [1]. Ever more drugs are
being developed, not least to deal with the ills of an
aging population [2]. Availability of both prescription
and non-prescription drugs is increasing and today’s global
mobility and Internet offer easy access to different types of
drugs, from herbal remedies to drugs of abuse [3]. At the
same time the amount of information accessible to the
public and advertisements for drugs in different media is
increasing. Communication between members of the
health professions and the public needs to be considered in
the light of these changes, and the professionals need to
sharpen their communicative skills around pharmaco-
logical issues, or as we prefer to see it, develop an ability to
draw on a depth of subject understanding to ensure patient
understanding. In a study of the pharmacological know-
ledge of final semester students from three health science
programmes (Aronsson et al, submitted) we have con-
cluded that “participants were able to define pharmaco-
logical concepts but showed less ability to discuss the
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meaning of the concepts in depth”. Here we focus on com-
municating such pharmacological knowledge in clinical
situations.
Across the broad spectrum of medical education, com-
munication between professionals and patients is receiv-
ing increased attention; as Simmenroth-Nayda, Weiss,
Fischer and Himmel [4] wrote, communication skills “are
particularly important in primary care settings where diag-
noses often may be obtained by an attentive history taking
alone. Moreover, patient outcomes such as drug adher-
ence, patient satisfaction and coping with illness depend,
amongst other things, on the doctor’s communication
abilities”. Diamantouror, Bartle and Geerts [5] add that for
“provision of high-quality education improves compliance,
increases time in the therapeutic range, and leads to a re-
duction in complications”. An extensive review of the lit-
erature [6] identifies three purposes of communication
between physicians and their patients, namely creating a
good interpersonal communication, exchanging informa-
tion and making treatment-related decisions, and con-
trasts the vocabulary of the profession with everyday
language. This complex view of what constitutes doctor-
patient communication can be related even to other
health care professions, with different factors being more
or less important according to the professional role. There
are calls to focus on communication throughout under-
graduate education programmes and in-service training
for medical professionals [7] – not only for future physi-
cians but also for other health related professions such as
dentistry [8] – and to study productive ways of enhancing
communication skills by introducing different virtual pa-
tient settings [9].
The literature on education and communication be-
tween medical professionals and their patients has three
distinct strands. First, there are curricular concerns in
terms of the content of medical education and its assess-
ment in an educational context [10] and methods for
teaching communication skills [11]. Second, there are
practical concerns in terms of evaluating programmes of
communication education or communication skills ac-
quired during medical training [12, 13]. And third, there
is concern for communication less as a skill and more as
an aspect of care for patients [14, 15]. Communicative
competence is stressed by Skelton [16], drawing atten-
tion away from having skills towards deploying them ap-
propriately, making the observation that communication
is fundamentally a moral enterprise.
The study is grounded in an interest in improving the
pedagogy of pharmacological communication in the health
sciences. The aim was to investigate and problematize
pharmacological communication in educational pro-
grammes for the health sciences as a first step. Spe-
cifically, the goal of the study is to chart the ways
in which final semester students articulate their
conceptions of the principal features of pharmaco-
logical communication in clinical cases – its nature
and its content – to provide an element of student
experience in the design and implementation of rele-
vant educational programmes.
Method
This study is part of a broader investigation on students’
understanding of pharmacological concepts (Aronsson
et al, submitted) and their communication in profes-
sional practice.
The data consists of interviews with 12 final semester
students from two Swedish universities (6 students
each), from three different programmes, so that the par-
ticipants include future doctors (4 students), future
nurses (4 students) and experienced nurses who have
trained to become specialist nurses in primary health
care with the right to prescribe drugs (4 students). There
was no intention to compare the performance of gradu-
ates from different programmes or from different univer-
sities, but the spread of backgrounds was intended to
give a qualitative variation relevant for all of them. The
study does not involve any handling of sensitive personal
data or clinical procedures. All interviewees gave their
informed consent prior to their inclusion in the study.
The project complies fully with current applicable Swedish
legal rules and ethical guidelines including the Helsinki
declaration.
The students were individually presented with two
written cases describing patients treated with a combin-
ation of drugs. The cases were designed to imitate a
common health care provider-patient interaction. The
study participants did not have access to Internet and
the only tool provided was a hardcopy of FASS, the
Swedish national drug formulary that provides health-
care professionals with detailed information about ap-
proved pharmaceuticals. Each student was given 30 min
(15 min per case) in which to identify the pharmaco-
logical problems and find possible solutions. Immedi-
ately thereafter, the student discussed the cases for
approximately 30 min with an interviewer (MR).
The two case descriptions
These two case descriptions were presented to the inter-
viewees for discussion. [Note that the contents of the
square brackets were not in the original case description;
only brand names were given].
Case A
Erik, age 56, comes for a follow-up visit at the health
care centre where you meet him. Erik had a myocardial
infarction 5 years ago and since then has been treated
with Plavix [clopidogrel, an inhibitor of platelet aggrega-
tion]. A year ago Erik was treated with Omeprazol
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[omeprazol; a proton pump inhibitor], prescribed for
symptoms of gastritis. The problems decreased but dur-
ing recent months they have reappeared with symptoms
of epigastralgia and nausea. Due to this Erik has started
the Omeprazol treatment again. He now reports in this
follow-up visit that he has been taking this drug for the
past few weeks.
Case B
You meet Gunvor, age 74, at the health care centre. She
has been using Trombyl [acetylsalicylic acid; 75 mg] for
many years as a “blood thinner” to prevent a myocardial
infarction and stroke. She now wants Trombyl replaced
by another drug. The reason she gives is that she has
read that Trombyl and Magnecyl [acetylsalicylic acid;
500 mg] are the same drug [acetylsalicylic acid]. She
often takes Magnecyl for headaches and claims to have
noted that Magnecyl has become less effective for pain
relief. Gunvor’s daughter has also read on the Internet
that Trombyl has a long effect duration with regards to
blood platelets and finds it strange that Magnecyl does
not last as long for headache. Gunvor asks if she can’t
take another pain killer such as Ipren [ibuprofen] or
Alvedon [paracetamol/acetaminophen] as a “blood thin-
ner” instead.
The interviews were semi-structured, designed and ex-
ecuted to capture as much of the students knowledge
and competence as possible. The opening questions for
a discussion on communication were:
 What is it important for Erik/Gunvor to
understand?
 How would you communicate this to him/her?
 Might there be obstacles for Erik/Gunvor to
understand your message?
 How would you deal with that?
The participants were asked these questions towards
the end of their interviews, after discussing the cases
from a purely pharmacological perspective. A paper sub-
mitted elsewhere focused on the students’ understanding
(Aronsson et al, submitted) of the pharmacological con-
cepts pharmacodynamics, pharmacokinetics and drug
interactions.
Theoretical framework
The study was conceptualised in a phenomenographic
methodological framework, which is to say that the re-
searchers were aiming to reveal the qualitative variation
of ways in which others understood the phenomenon in
focus. Stenfors-Hayes, Hult and Dahlgren [17] introduce
the research approach for particular use in medical edu-
cation; Fyrenius, Silén and Wirell [18] make use of it to
understand students’ meaning-making in a PBL context;
and Marton and Booth [19] develop a theory of learning
grounded in empirical research results.
Phenomenography is an empirical educational research
approach, where a phenomenon is focused on in terms of
the variation of ways in which people experience (or con-
ceptualise, see or think about) it; this is to take a second-
order perspective on the phenomenon, in contrast to
research from a first-order perspective where it is the
phenomenon as it exists in the world that is in focus. As a
simple example, from a second order perspective, many
people conceptualise tooth cavities as being caused by eat-
ing unsuitable foods, or by failing to brush enough, while
from a first order perspective it is bacteria that cause the
dental decay. The data collected for phenomenographic
research is most often in the form of semi-structured
open-ended interviews in which the phenomenon is con-
sidered from different openings, such as those that under-
pin this study. Analysis is often conducted in groups of
educational researchers and subject specialists, as the con-
stellation of pharmacological and educational researchers
responsible for this article. The results are presented as a
set of categories, called the outcome space of the study,
which describe the variation in terms of qualitatively dis-
tinct categories that are related to the phenomenon rather
than categorizing the individuals who voiced them.
It is the variation in the meaning that is expressed across
the whole set of interviews that is of interest, rather than
differences between individuals, as an individual can con-
tribute to more than one category. As already stated, we
are not comparing graduates from different universities,
categories of future medical professionals or studying
communication in authentic settings; what we are doing is
to demonstrate that there are qualitatively different ways
of conceptualising such communication across the set of
interviews. We wish to understand what distinguishes one
category from another as well as what constitutes a more
complete and complex conceptualisation.
Results
Two main thematic aspects were identified as constituting
the phenomenon of pharmacological communication:
 What is pharmacological communication with a
patient understood to be?
 What is seen to be the pharmacological content of
the communication?
In this section, these two thematic aspects of com-
munication are used as an organisational framework
and will be described in terms of the qualitative
variations found – as phenomenographic outcome
spaces – illustrated by extracts from the interviews.
The interviewees are identified by the order in which
they were interviewed.
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Thematic aspect 1: What is pharmacological
communication with a patient understood to be?
The analysis gave four qualitatively different ways of un-
derstanding the nature of pharmacological communica-
tion between the health care professional and the patient,
varying basically between giving information, two-way
communication on the medical professional’s premises,
building communication on a hypothetical understanding
of the patient and establishing the patient’s understanding
from the outset.
Category 1. You give information, in the form of instruction
and explanation
In this category the expression is of a one-way communi-
cation where the medical professional tells and the patient
passively listens. One refers to the authority of FASS as a
basis of information:
S2: I would have, well, I’d have gone to FASS
and that’s why you have to understand these
different concepts so that I’d be able to explain.
And then I’d have explained what I found there
Another student focuses on the potential consequences
of Gunvor’s actions:
S6: I’d explain as simply as possible in ordinary Swedish
that it is pretty dangerous to take these medicines
together, the risk of haemorrhage gets much higher
Category 2. You give information and check that the
patient has understood
Now, the patient also has a role to play in potential
communication after the consultation, as described here:
S5: […] maybe I could ring her and ask how it’s going
later on […] and if it seems a bit shaky so maybe I’d have
to meet her in person and if it seems she still doesn’t
understand it all – but I don’t want her to go home with
questions but I would really want her to understand it
there and then, so I’d call her up quite soon after. Her
daughter is mentioned here, but I don’t know how their
relation is. Would she want me to talk to her daughter?
Still, the patient is expected to be able to repeat, or
ask apparently relevant questions about, or refer to a
relative about what they have been told.
Category 3. You build your information on a hypothetical
understanding of the patient and their understanding
In this third category, the health care professional takes
a step further and contemplates what the patient might
already understand, or might be capable of understand-
ing, as here:
S6: Well, I don’t know much about her actually. I know
she is 74 and that … but who she is as a person, is she
fully aware, is she senile, can she absorb information?
There, outward signs of the patient’s potential for
communication are considered, whereas in the next
extract more general attitudes are touched upon.
S5: It depends on what the patient thinks about
medicine, I think. Something you meet quite often is
“I don’t like to take medicine, I don’t like tablets, the
fewer tablets the better”
In either case, such contemplation can inform the com-
munication that follows.
Category 4. You investigate what the patient understands
and take it as a starting point for giving your information
In this, the most complex category, the health care pro-
fessional takes an inquiring approach and establishes the
patient’s potential for communication before embarking
on an explanation or discussion on the medication
S5: Yes, it’s important to investigate and wonder why
she has headaches so often that she needs to take
Magnecyl. […] She seems to have got the idea that the
Trombyl isn’t working and we need to get her on
board that it actually is working even if it isn’t helping
against the headaches. Because it seems it’s there she
goes “if it isn’t helping with this then it’s not helping
with that either”
and:
S3: Well, first you can ask her what she thinks, how
she believes it is working. What she has the medicine
for and how she thinks it is working. So she can
explain in her own words…
These four categories refer to a general competence
for communicating pharmacological advice, a relation
between the health care professional and the patient. But
all communication has content – the focus of the con-
versation that ensues. In this study the content was the
medication that Erik and Gunvor were taking and the
consequences of changing circumstances; this is the
second theme of the phenomenographic analysis.
Thematic aspect 2. What is seen to be the content of the
pharmacological communication?
Three qualitatively different ways of seeing the content
of the communication have been derived from the data,
stripped of the actual pharmacological focus, but again
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ordered in a hierarchy from the least to the most com-
plex and complete. The content concerns first what the
patient must do, followed by, second, a justification of
that, and third, explanation of different aspects of the
medication.
Category 1. Instructions for adherence
First, the content of the pharmacological communication
is that the prescribed drugs must be taken as instructed:
S1: I think I am quite strict, so I want her to
understand that she isn’t allowed to combine them, for
exactly as she has already understood, they are exactly
the same ingredients but that one has a much higher
dose than the other
Category 2. Justification of why the patient should act in a
certain way
In this category, instructions for adherence are as-
sumed and justification becomes the content of the
communication:
S4: I would simply ask him what he knows about his
medication and why he is taking them, because I know
that’s important for compliance…
Category 3. Explanation of the relation between medicine,
symptoms and potential consequences
In this third category, adherence and justification are
complemented by explanation:
S6: I’d tell her that because she is taking blood thinners
for her heart attack and stroke because I want her
blood to flow more easily, then if we increase that
effect with Magnecyl then there is the risk that if she
gets a knock she’ll get bruises and will bleed.
Even S4, cited above, goes on to say:
S4: And if he doesn’t know I’d explain for him and
encourage him to take both [Plavix and Omeprazol]
so that… I don’t want to scare him too much but he
could run a certain risk for bleeding ulcers.
These three categories form the outcome space in re-
lation to the second thematic aspect: “What is seen to
be the content of the pharmacological communication?”
and give a picture of increasing trust in the ability of the
patient to understand the reasons for medication. Rarely
does the content of communication, as expressed in the
study, involve finding out what the patient already un-
derstands of the symptoms and the medication, and that
has to be seen as a shortcoming across the participants
in the study.
Discussion
This study shows that the variation in ways of under-
standing communication can vary from one-way instruc-
tion on how to act, to a two-way discussion where the
patients’ understanding is elicited prior to an explan-
ation of the symptoms and the diagnosis that is to be
treated. It needs to be followed up with a study that
can examine relations between depth of understand-
ing pharmacological processes and ability to commu-
nicate them to patients. While it is not a study of
communication in authentic clinical settings, it does
highlight the fact that even in authentic clinical set-
tings there are limits to the ways in which we can ex-
pect health care professionals to act; a person cannot
be expected to communicate in a way that they are
unable to articulate in a deep interview.
The structure of the outcome spaces
The categories of the first outcome space, “What is
pharmacological communication with a patient under-
stood to be?” clearly form a hierarchy of less complex
and less satisfactory to more complex and more complete
ways of conceptualising pharmacological communication.
The categories do not simply become more complex or
additive, but they rather grow in engagement with the pa-
tient to take account of his or her concerns. What can this
tell us about communication practices in clinical settings?
In general, the capability for communicating is delimited
by the way in which communication is conceptualised.
One can imagine that a health professional, as S3, who is
able to respond: “Well, first you can ask her what she
thinks, how she believes it is working” from the fourth cat-
egory, with the intention of finding out what the patient
thinks about her medication, is more likely to encourage
dialogue and mutual understanding than one who is lim-
ited to the first category, who would turn to the authorita-
tive catalogue, as S2 does, and try to explain what he or
she finds there, “I would have, well, I’d have gone to
FASS”.
The hierarchical relationship of the second outcome
space, the different ways in which the participants ex-
press the content of pharmacological communication, is
less clear than their expression of the ways in which
communication should be conducted. Certainly, the
third category, where the patient is introduced to an ex-
planation and prognosis, is most satisfying for a patient
who can grasp and is interested in the details. The first
and second, justifying adherence as they do, are also es-
sential for an understanding of the importance to follow
the medication regimen prescribed. An ideal response
would take up all three, telling the patient what she may
and may not do with an explanation of why that is
so, and the consequences of the medicine for the
symptoms.
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Consequences for teaching and learning in pharmacology
Earlier work with a phenomenographic approach to re-
vealing qualitative differences in how students conceptu-
alise phenomena of importance to their studies have
made use of the variation they found in designing learn-
ing tasks [20]. It is necessary for a student to become
aware that his or her taken-for-granted approach to
communication could be otherwise. A physician, for in-
stance, who sees her or his role as offering correct infor-
mation (as in the first category) needs to understand
that the information is not necessarily clear to the pa-
tient, and that hypotheses or investigations are needed
to establish good communication (as in later categories).
A nurse, for instance, who thinks that the advice given
to a patient should focus on adherence to instruction (as
in the first category) needs to become aware that in
order to ensure adherence, the patient needs to be of-
fered the opportunity to relate symptoms and diagnoses
to the necessary medication (as in the third category).
Learning tasks, formulated as case studies or problems
or role-playing exercises in courses in pharmacology,
can be designed to open such variation of communica-
tive approaches to students and thereby lead to discus-
sions of what constitutes effective communication.
Further, it enables assessment procedures to be based on
an understanding of the complexity and completeness of
approaches and content.
The results of the study can be compared with those
to be found in the literature, revealed in ways other than
that of our empirical research study. According to
Moore, Wilkinson and Mercado [21] “research suggests
that communication skills do not reliably improve with
experience alone”, and although this is said in relation to
communication around medical and psychological issues
of cancer patients, it still puts considerable responsibility
for ensuring that the basis of communication skills is
laid down in higher education. One generally acknowl-
edged tool for evaluating communication skills is the
Kalamazoo Consensus Statement (KCS). This identifies
essential elements of physician-patient communication
as establishing rapport, opening discussion, gathering
information, understanding a patient’s perspective of ill-
ness, sharing information, reaching agreement on prob-
lems and plans, and providing closure [22, 23]. The
criticism that can be levelled at such generalised evalu-
ation tools is that they neglect the specific content of the
communication, the knowledge that the medical profes-
sional wishes the patient to understand and act on, here
pharmacological knowledge. Within the confines of the
case descriptions provided for the interviews in this
study, most of the KCS elements came out in discussion,
and those were in the more complex and complete cat-
egories of the outcome spaces. Hence, we suggest that
these elements should be central considerations when
designing education for communication skills and for
evaluating the results.
Our analysis of the pharmacological knowledge of final
semester students (Aronsson et al, submitted) indicates
clearly that a thorough knowledge of the fundaments of
pharmacology is essential for adequate communication.
However, a good knowledge of the field does not neces-
sarily ensure a good communication skill, as our study
participants sometimes expressed when asked about ob-
stacles to communication. A future research study could
build on the results of these two studies to consider
links between content knowledge and communication
approach across a wider range of final semester
students.
As we have already pointed out indirectly, the study
has certain limitations. First, it is based on students’
discussions rather than on their actions, but this has
enabled us to explore and chart the conceptions of
communication held by final semester students across
health sciences; it could act as grounding for a more
observational study. Secondly, the number of inter-
viewed students is relatively small, though it does
cover a wide range of backgrounds; it could, however,
act as a pilot for a questionnaire-based study of a lar-
ger number of graduating students with the possibility
of correlating communication skills with knowledge of
pharmacology. Thirdly, the implications for teaching
practice are only outlined; it could, however, act as a
framework for the design and evaluation of the ele-
ments of health science educational programmes that
build communication skills.
A course in communication, we can conclude, must
not simply focus on handling well-understood informa-
tion in a stylised manner; pharmacological communica-
tion needs to be integrated into subject matter courses
and practical work. Simmenroth-Nayda et al. [4] also
conclude “[Communication skills] should be taught
more in a problem-based method (“experimental”) than
with instructional teaching methods”. We can add here
that role playing and case-based studies offer similar op-
portunities for students at the end of their studies to be
exposed to the issues of pharmacological communica-
tion across their specialisations.
Conclusion
In this paper we have presented a study of understand-
ing pharmacological communication in terms of the
variation in ways in which final semester students of the
health professions give expression to their potential for
communication with patients in two different commonly
occurring situations. The picture we have presented is
not quantitative in nature, but gives a more nuanced
qualitative description of what constitutes the under-
standing of communication. Further, we have suggested
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how it can provide an input into improving skills in
pharmacological communication in the health science
programmes.
In summary we have shown that:
 There is a qualitative variation in how final
semester health care students approach issues
of communicating pharmacological information,
that has implications for the outcome of the
communication.
 Health science students need to develop an ability
to draw on a depth of understanding of
pharmacological processes to ensure patient
understanding and, thence, adherence.
 Communication skills needs to be considered as an
essential and integrated aspect of health science
education
Our last word is taken from the words of Henning
Mankell, the internationally known Swedish author, who
wrote of his treatment for cancer in The Guardian [24].
“But the doctors I remember most clearly are those who
have displayed what can be described, certainly by me,
as the innermost subtleties of the art of medical treat-
ment. Alleviation, consolation, perhaps even cure, always
involves a dialogue in which the patient and doctor learn
how to talk to one another, and if possible create con-
tinuity. Medication and other treatments are never
enough in themselves. If the patient doesn't understand
what the doctor is saying, or if the doctor is unwilling or
unable to interpret the questions and worries of the pa-
tient, the dialogue that is at the very heart of medical
treatment will never materialise.” This places our peda-
gogical concern in a wider context of the patients and
what they experience and appreciate in “the dialogue
that is at the very heart of medical treatment”.
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